ES2172731T3 - Composicion farmaceutica oral que tiene actividad antipiretica, analgesica y antiinflamatoria. - Google Patents

Composicion farmaceutica oral que tiene actividad antipiretica, analgesica y antiinflamatoria.

Info

Publication number
ES2172731T3
ES2172731T3 ES97120067T ES97120067T ES2172731T3 ES 2172731 T3 ES2172731 T3 ES 2172731T3 ES 97120067 T ES97120067 T ES 97120067T ES 97120067 T ES97120067 T ES 97120067T ES 2172731 T3 ES2172731 T3 ES 2172731T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
antipiretic
analgesical
inflammatory activity
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97120067T
Other languages
English (en)
Inventor
Massimiliano Borsa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LEETRIM Ltd DUBLIN
SINTACTICA Srl
Original Assignee
LEETRIM Ltd DUBLIN
SINTACTICA Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEETRIM Ltd DUBLIN, SINTACTICA Srl filed Critical LEETRIM Ltd DUBLIN
Application granted granted Critical
Publication of ES2172731T3 publication Critical patent/ES2172731T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA EN FORMA DE UNA SUSPENSION APROPIADA PARA ADMINISTRACION ORAL QUE CONTIENE COMO PRINCIPIO ACTIVO UN COMPUESTO ANTIINFLAMATORIO NO ESTEROIDEO EN UNA CANTIDAD DEL 1 AL 5 % DEL PESO CON RESPECTO AL VOLUMEN DE LA SUSPENSION. LA SUSPENSION TIENE UTILIDAD EN AQUELLAS SITUACIONES PATOLOGICAS QUE SE CARACTERIZAN POR FLOGOSIS, HIPERPIREXIA Y DOLOR.
ES97120067T 1996-11-20 1997-11-17 Composicion farmaceutica oral que tiene actividad antipiretica, analgesica y antiinflamatoria. Expired - Lifetime ES2172731T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI002423A IT1286496B1 (it) 1996-11-20 1996-11-20 Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria

Publications (1)

Publication Number Publication Date
ES2172731T3 true ES2172731T3 (es) 2002-10-01

Family

ID=11375253

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97120067T Expired - Lifetime ES2172731T3 (es) 1996-11-20 1997-11-17 Composicion farmaceutica oral que tiene actividad antipiretica, analgesica y antiinflamatoria.

Country Status (4)

Country Link
EP (1) EP0843998B1 (es)
DE (1) DE69710423D1 (es)
ES (1) ES2172731T3 (es)
IT (1) IT1286496B1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291278B1 (it) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico
IT1291895B1 (it) 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CN1327381A (zh) * 1999-10-20 2001-12-19 帝人株式会社 水性药物组合物
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US20060093631A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
US20060093630A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
PT1824493E (pt) 2004-12-06 2008-11-18 Janssen Pharmaceutica Nv Suspensão oral que compreende meloxicam
GB2438287A (en) 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
CH663899A5 (fr) * 1985-03-20 1988-01-29 Nestle Sa Procede pour la preparation d'une composition a base d'un principe actif de faible hydrosolubilite finement divise.
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物

Also Published As

Publication number Publication date
EP0843998A1 (en) 1998-05-27
IT1286496B1 (it) 1998-07-15
ITMI962423A1 (it) 1998-05-20
EP0843998B1 (en) 2002-02-13
ITMI962423A0 (it) 1996-11-20
DE69710423D1 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
ES2172731T3 (es) Composicion farmaceutica oral que tiene actividad antipiretica, analgesica y antiinflamatoria.
CO5050325A1 (es) Composiciones que contienen acidos difosfonicos
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
DK0902789T3 (da) Androstenderivater
FI971188A0 (fi) Terapeuttinen vitamiini-kalsium yhdistelmä yksikköannoksena galeenisen tabletin muodossa, menetelmä sen valmistamiseksi ja sen käyttö
ID23806A (id) Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin
ES2080844T3 (es) Composiciones administradas topicamente basadas en acido hialuronico de alto peso molecular para el tratamiento de las inflamaciones de la cavidad oral y para la higiene y el tratamiento cosmetico de la cavidad oral.
BG102857A (en) Antimycotic substance-containing and acetate buffer-containing compositions
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
AR040036A1 (es) Tratamiento de la mucositis
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
ES2054718T3 (es) El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica.
NL7803247A (nl) Preparaat ter bestrijding van ontsteking.
BR0008657A (pt) Comprimidos deglutìveis com teor elevado den-acetilcisteì na e processo para a preparação dosmesmos
ES2147163A1 (es) Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.
IT1232819B (it) Impiego di sorgenti di nucleobasi per stimolare la funzione immunitaria, relativo procedimento e composizioni farmaceutiche contenenti una tale sorgente di nucleobasi
ES2082023T3 (es) Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.
ES2058999T3 (es) Formas de administracion orales solidas que contienen ifosfamida como sustancia activa.
CO5180574A1 (es) Micofenolato mofetil en asociacion con peg-inf-a
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
ATE293432T1 (de) Kosmetische oder pharmazeutische zubereitungen für die topische verabreichung mit verbesserter stabilität
AR027038A1 (es) Metodo y composicion para el tratamiento del dolor

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 843998

Country of ref document: ES